eHealth Technologies, a healthcare technology company, will join CancerX, a public-private partnership acting as a national accelerator, to boost innovation in the fight against cancer.
Researchers at Moffitt Cancer Center have been awarded a $22.4 million grant from the U.S. Department of War to lead studies and clinical trials for leptomeningeal disease, a devastating complication of breast and other cancers that spreads to the coverings of the brain and spinal cord.
